Search stocks

Find any stock by ticker or company name

Home

GUTS

Fractyl Health, Inc. (GUTS)

NGM – Real vaqt narxi. Valyuta: USD

0.70

-0.01 (-0.83%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

0.70

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:04 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

GUTS - Fractyl Health, Inc. So'nggi Yangiliklar | Finranks

Home

GUTS

Fractyl Health, Inc. (GUTS)

NGM – Real vaqt narxi. Valyuta: USD

0.70

-0.01 (-0.83%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

0.70

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:04 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

11.08.2026

Fractyl Health, Inc. (GUTS) Q2 2026 Earnings Call Transcript

10.08.2026

Fractyl Health Q2 Earnings Call Highlights

Fractyl Health NASDAQ: GUTS said its Revita endoscopic procedure showed durable weight-maintenance results one year after patients discontinued GLP-1 therapy, while the company reaffirmed plans to report pivotal trial data in early fourth-quarter 2026 and pursue a potential FDA De Novo submission later in the year.

03.08.2026

Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026

BURLINGTON, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced that it will report financial results for the second quarter 2026 and provide business updates on Monday, August 10, 2026, at 4:30 p.m. ET.

Videolar

No Data

There is no data to display